💊Request for Comments on National Security Investigation of Pharmaceuticals
Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
Summary
The Secretary of Commerce initiated an investigation to determine the effects on the national security of imports of pharmaceuticals and pharmaceutical ingredients, including finished drug products, medical countermeasures, critical inputs such as active pharmaceutical ingredients, and key starting materials, and derivative products of those items. This investigation has been initiated under section 232 of the Trade Expansion Act of 1962, as amended. Interested parties are invited to submit written comments, data, analyses, or other information pertinent to the investigation to the Department of Commerce's (Department) Bureau of Industry and Security (BIS), Office of Strategic Industries and Economic Security. This notice identifies issues on which the Department is especially interested in obtaining the public's views.
Agencies
- Commerce Department
- Industry and Security Bureau
Business Impact
$$$ - High
The notice invites public comments on the national security investigation of pharmaceutical imports, directly affecting businesses in the pharmaceutical industry, potentially leading to compliance or regulatory changes and impacting trade practices. The emphasis on economic implications suggests possible financial repercussions for industry stakeholders.